Afrezza Insulin Inhaler is available in the market since early 2015. It behaves like normal pancreatic insulin. It means that if you take a dose and don't eat, your sugar level won't dip to dangerous levels suddenly. However, if you have long-term lung problems like asthma or chronic obstructive pulmonary disease (COPD), you should not take it.
